FdaApplication
NDA 020164
Identifiers
- fda_app_no: NDA020164
Properties
| Property | Value |
|---|---|
| applicant_name | SANOFI AVENTIS US LLC |
| application_type | NDA |
| approval_date | 1993-03-29 |
Products (9)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOVENOX | ENOXAPARIN SODIUM | 300MG/3ML (100MG/ML) | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 30MG/0.3ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 100MG/ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 60MG/0.6ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 40MG/0.4ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 150MG/ML (150MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 80MG/0.8ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 120MG/0.8ML (150MG/ML) | INJECTABLE;SUBCUTANEOUS |
9 products